Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7024917 [patent_doc_number] => 20050019311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Flow electroporation chamber and method' [patent_app_type] => utility [patent_app_number] => 10/846729 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22286 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019311.pdf [firstpage_image] =>[orig_patent_app_number] => 10846729 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/846729
Flow electroporation chamber and method May 13, 2004 Abandoned
Array ( [id] => 4999709 [patent_doc_number] => 20070042343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Forward mutation assay based on 5-fluorouracil resistance' [patent_app_type] => utility [patent_app_number] => 10/554433 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16077 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042343.pdf [firstpage_image] =>[orig_patent_app_number] => 10554433 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554433
Forward mutation assay based on 5-fluorouracil resistance Apr 21, 2004 Issued
Array ( [id] => 6927756 [patent_doc_number] => 20050241013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization' [patent_app_type] => utility [patent_app_number] => 10/829081 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1349 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20050241013.pdf [firstpage_image] =>[orig_patent_app_number] => 10829081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/829081
Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization Apr 21, 2004 Abandoned
Array ( [id] => 7468098 [patent_doc_number] => 20040198972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Processes for the preparation of oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/828659 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15646 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198972.pdf [firstpage_image] =>[orig_patent_app_number] => 10828659 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828659
Processes for the preparation of oligonucleotides Apr 20, 2004 Abandoned
Array ( [id] => 6996262 [patent_doc_number] => 20050136040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Control of gene expression using a complex of an oligonucleotide and a regulatory peptide' [patent_app_type] => utility [patent_app_number] => 10/824584 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18645 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136040.pdf [firstpage_image] =>[orig_patent_app_number] => 10824584 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/824584
Control of gene expression using a complex of an oligonucleotide and a regulatory peptide Apr 7, 2004 Abandoned
Array ( [id] => 4866288 [patent_doc_number] => 20080145347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => ' p-Hyde sequences in the Rat' [patent_app_type] => utility [patent_app_number] => 10/807517 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 41238 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145347.pdf [firstpage_image] =>[orig_patent_app_number] => 10807517 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/807517
p-Hyde sequences in the Rat Mar 23, 2004 Abandoned
Array ( [id] => 5754619 [patent_doc_number] => 20060223768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Regulation of gene expression' [patent_app_type] => utility [patent_app_number] => 10/549711 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5939 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223768.pdf [firstpage_image] =>[orig_patent_app_number] => 10549711 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/549711
Regulation of gene expression Mar 16, 2004 Abandoned
Array ( [id] => 7351511 [patent_doc_number] => 20040248841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Poly-DNP-siRNA' [patent_app_type] => new [patent_app_number] => 10/801118 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3383 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248841.pdf [firstpage_image] =>[orig_patent_app_number] => 10801118 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/801118
Poly-DNP-siRNA Mar 14, 2004 Abandoned
Array ( [id] => 7318839 [patent_doc_number] => 20040224889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Using polyamide nucleic acid oligomers to engender a biological response' [patent_app_type] => new [patent_app_number] => 10/799238 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26756 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224889.pdf [firstpage_image] =>[orig_patent_app_number] => 10799238 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/799238
Using polyamide nucleic acid oligomers to engender a biological response Mar 11, 2004 Abandoned
Array ( [id] => 7256997 [patent_doc_number] => 20040259912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Benzine derivatives, process for preparing the same and use thereof' [patent_app_type] => new [patent_app_number] => 10/489621 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70856 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259912.pdf [firstpage_image] =>[orig_patent_app_number] => 10489621 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/489621
Benzine derivatives, process for preparing the same and use thereof Mar 11, 2004 Abandoned
Array ( [id] => 7426734 [patent_doc_number] => 20040229831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Compositions and methods for non-parenteral delivery of oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/793497 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30623 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229831.pdf [firstpage_image] =>[orig_patent_app_number] => 10793497 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793497
Compositions and methods for non-parenteral delivery of oligonucleotides Mar 3, 2004 Abandoned
Array ( [id] => 7316846 [patent_doc_number] => 20040224019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs' [patent_app_type] => new [patent_app_number] => 10/791989 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15102 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224019.pdf [firstpage_image] =>[orig_patent_app_number] => 10791989 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/791989
Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs Mar 2, 2004 Abandoned
Array ( [id] => 6437855 [patent_doc_number] => 20100144038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell' [patent_app_type] => utility [patent_app_number] => 10/594349 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 31607 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144038.pdf [firstpage_image] =>[orig_patent_app_number] => 10594349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594349
Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell Mar 2, 2004 Abandoned
Array ( [id] => 5672970 [patent_doc_number] => 20060178325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Modulation of growth hormone receptor expression and insulin-like growth factor expression' [patent_app_type] => utility [patent_app_number] => 10/547239 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178325.pdf [firstpage_image] =>[orig_patent_app_number] => 10547239 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547239
Modulation of growth hormone receptor expression and insulin-like growth factor expression Feb 26, 2004 Issued
Array ( [id] => 7328728 [patent_doc_number] => 20040253723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Modulation of growth hormone receptor expression and insulin-like growth factor expression' [patent_app_type] => new [patent_app_number] => 10/789526 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28872 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253723.pdf [firstpage_image] =>[orig_patent_app_number] => 10789526 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/789526
Modulation of growth hormone receptor expression and insulin-like growth factor expression Feb 25, 2004 Issued
Array ( [id] => 5625259 [patent_doc_number] => 20060263764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Methods and constructs for evaluation of rnai targets and effector molecules' [patent_app_type] => utility [patent_app_number] => 10/547256 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6454 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263764.pdf [firstpage_image] =>[orig_patent_app_number] => 10547256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547256
Methods and constructs for evaluation of rnai targets and effector molecules Feb 23, 2004 Abandoned
Array ( [id] => 7011389 [patent_doc_number] => 20050065105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Modulation of APPL expression' [patent_app_type] => utility [patent_app_number] => 10/785168 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7631 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065105.pdf [firstpage_image] =>[orig_patent_app_number] => 10785168 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/785168
Modulation of APPL expression Feb 22, 2004 Abandoned
Array ( [id] => 7432395 [patent_doc_number] => 20040162260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Reversible attachment of a membrane active polymer to a polynucleotide' [patent_app_type] => new [patent_app_number] => 10/780484 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7037 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162260.pdf [firstpage_image] =>[orig_patent_app_number] => 10780484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/780484
Reversible attachment of a membrane active polymer to a polynucleotide Feb 16, 2004 Issued
Array ( [id] => 7428347 [patent_doc_number] => 20040161799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'KOR3like-proteins and methods of modulating KOR3L-mediated activity' [patent_app_type] => new [patent_app_number] => 10/779104 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6847 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161799.pdf [firstpage_image] =>[orig_patent_app_number] => 10779104 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/779104
KOR3like-proteins and methods of modulating KOR3L-mediated activity Feb 12, 2004 Abandoned
Array ( [id] => 7061024 [patent_doc_number] => 20050003385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Isolated DNA or gene responsible for Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 10/776604 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13084 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003385.pdf [firstpage_image] =>[orig_patent_app_number] => 10776604 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776604
Isolated DNA or gene responsible for Parkinson's disease Feb 11, 2004 Abandoned
Menu